Deca-Durabolin is a clear, yellow, oily liquid containing 50 mg / ml of the active ingredient nandrolone decanoate. Nandrolone belongs to the group of medicines known as anabolic steroids or short anabolic steroids.
Deca-Durabolin is an anabolic steroid for injection. After Deca-Durabolin is injected into the muscle, nandrolone decanoate is slowly released from the oily solution into the blood, where it is converted into nandrolone by your body. In fact, nandrolone is the active ingredient. The decanoate is only included to give the medicine a lasting effect of three weeks.
Nandrolone is chemically closely related to the male sex hormone (testosterone). In men, testosterone causes the typical male characteristics (androgenic effect). In addition, it stimulates the formation of tissue protein (anabolic effect). Compared with testosterone, nandrolone has a stronger anabolic, but a weaker androgenic effect.
Nandrolone also helps to rebuild bone mass. Therefore, Deca-Durabolin is used to increase bone mass in the case of osteoporosis ( bone loss ). Osteoporosisoccurs mainly in postmenopausal women. It is characterized by the fact that the bones are brittle and break easily, and this causes discomfort such as back and bone pain. Treatment with Deca-Durabolin can increase bone mass and ease these symptoms.
Deca-Durabolin can be used to supplement certain therapies and dietary measures to treat muscle breakdown caused by certain diseases (lung disease, kidney disease, AIDS ).
Deca-Durabolin is a clear, yellow, oily liquid containing 50 mg / ml of the active ingredient nandrolone decanoate. After Deca-Durabolin is injected into the muscle, nandrolone decanoate is slowly released from the oily solution into the blood, where it is converted into nandrolone by your body.
Deca-Durabolin must not be used
If you are allergic to nandrolone decanoate or any of the other ingredients of this medicine (listed in section 6). Deca-Durabolin contains peanut oil. Therefore, Deca-Durabolin should not be used if you are allergic to peanut or soy.
if you are a man with an existing or suspected prostate or breast cancer .
if you have porphyria (metabolic disorder). or suffered.
Please talk to your doctor before using Deca-Durabolin.
If you notice signs of masculinization (eg lower voice, increased facial hair growth), talk to your doctor immediately.
Treatment with Deca-Durabolin may increase the size of the prostate, especially in elderly male patients. Therefore, your doctor will periodically perform a digital rectal exam (DRE) and blood tests to determine the prostate-specific antigen (PSA) to examine your prostate.
In all patients, blood tests will be performed at regular intervals to check the oxygen-binding substance (hemoglobin) in the red blood cells. In very rare cases, the number of red blood cells increases too much, which leads to complications (polycythemia).
Medical examinations / monitoring may also be necessary in other cases. Therefore, before you use this medicine, tell your doctor or pharmacist if you have suffered from, or suspected of suffering from the following conditions:
Due to the nature of Deca-Durabolin, side effects due to discontinuation of the drug are only slowly reversible. With continued therapy, some side effects (eg, symptoms and signs of virilization) may also be irreversible (permanent). Deca-Durabolin can cause a local reaction at the injection site.
Depending on dosage, frequency and total duration of application, the following side effects may occur:
Water retention in the tissue, usually noticeable on the ankle or feet (edema).
Propagation of all blood cells (polycythemia)
Increase in hemoglobin levels or blood lipids.
Hepatic impairment (including cyst formation in the liver [Peliosis hepatis]).
increased or decreased sexual desire
Disturbance of the voice (dysphonia)
Hoarseness (this may be the first sign of a change in the voice that can be long-lasting or sometimes permanent)
increased body or facial hair (hirsutism).
Hair loss ( alopecia )
irregular menstrual bleeding or complete absence of menstrual bleeding)
Enlargement of the clitoris
impaired sperm production, reduced sperm count in ejaculation
benign prostate enlargement with urinary problems (reduced urinary flow)
Growth of a small prostate carcinoma , which until then was undetected
elevated laboratory values (PSA) indicating prostate cancer
painful erections (priapism)
Enlargement of the breast (gynecomastia)
Deca 300 Dragon Pharma, Deca 500 Dragon Pharma, Nandro F Magnus Pharma, Deca 300 Maha Pharma, NPP 150 SINGANI PHARMA